ABOUT US
Rethinking surgery.
We enable safe and efficient monitoring of tissues during cancer surgery without compromising workflows.
VISION
Better surgical outcomes with an informed minimally invasive approach
Our vision is to be the leading manufacturer of aspirate tissue monitoring solutions by 2029.
Marginum is developing ground-breaking tissue recognition technology, especially for oncological surgery. Our technology assists in safe and efficient identification of cancerous tissue with minimal damage to healthy tissues.
There is a globally growing need for efficient oncological treatments and accurate tissue identification is one of its biggest challenges during surgery. With our data-driven technology, we aim to radically improve surgical performance and patient outcomes. We prioritise patient welfare and adhere to the highest level of professionalism in everything we do. We respect the individual and by embracing diversity of thought, experience and background – we foster continuous learning and curiosity to deliver tangible value and lasting positive change. Our company can only be as successful as our team members and customers are.
Marginum’s timeline
Marginum’s pioneering work to radically improve surgical outcomes has already led to technological breakthroughs and received several academic and business awards.
FUTURE
PAST
TEAM
Our team of multidisciplinary experts
Marginum is a medical device company based in Kuopio, Finland. Our team consists of multidisciplinary experts dedicated to improving surgical workflows with data-driven solutions.
Samu Lehtonen
MD
Chief Executive Officer
Business & Operation
Antti-Pekka Elomaa
MD PhD A/Prof Neurosurgery
Chairman of Board
Education & Design
Juho Leskinen
MEng
Chief Technology Officer
Engineering & Commercialization
Joonas Konki
PhD
Chief Scientific Officer
Scientific Research & Discovery
Mikko Hallanoro
MSc
Chief Business Officer
Business Development & Sales
Liisa McDonald
RN
Executive Assistant
Operations & Coordination
Dmitry Semenov
PhD
Scientific Liaison
Prototyping & Optical systems
Sami Puustinen
MD PhD
Chief Medical Officer
Clinical Evaluation & Discovery
Tuomas Säteri
MD
Clinical Trial Physician
Clinical Trials & Support
EXECUTIVE ADVISORY BOARD
Global key opinion leaders in surgical technology
Marginum is privileged to work together with clinical partners and global key opinion leaders in the field of neurosurgery and surgical technology.
Professor Dr. Fady T. Charbel
MD PhD FAANS FACS
Professor Fady T. Charbel is an internationally recognised key opinion leader in neurosurgery and mini-invasive surgical technology; awarded the prestigious AANS Cushing Award for Technical Excellence and Innovation in Neurosurgery. He is the Head of the Department of Neurosurgery at University of Illinois and has guided several medical innovations to the global markets (Transonic Systems Charbel Micro-Flow Probe®, VasSol NOVA® flow-analysis system).
Dr. Maria Severina
PhD
Dr. Maria Severina has several decades of experience in high-quality development and product deployment across multiple industries and technologies, bringing businesses to successful commercialisation. Dr. Severina founded HyTest, the world’s leading antibody manufacturer and served as CEO for 26 years. She is a Board Member of several life science companies, including US-based Meridian Bioscience, and is actively involved with investments in life science start-up companies.
Kaj Hagros
MSc MBA
Kaj Hagros is Managing Partner at Redstone Nordics and has a broad history as an entrepreneur, investor and C-level executive with 25 years of experience. He is a board professional and has executed a wide array of early-stage investments and successful exits, and worked as CEO of Nasdaq Helsinki traded Tecnotree Corporation, COO of FOX Mobile and Head of Strategy & Business Development at Nokia Networks.